| 13. |
INCOME TAX |
At December 31, 2016 and 2015, based on the weight of available evidence, management determined that it was unlikely that the Company's deferred tax assets would be realized and have provided for a full valuation allowance associated with the net deferred tax assets.
The Company periodically analyzes its tax positions taken and expected to be taken and has determined that since inception there has been no need to record a liability for uncertain tax positions. The Company classifies income tax penalties and interest, if any, as part of selling, general and administrative expenses in the accompanying statements of operations. There was no accrued interest or penalties as of December 31, 2016 and 2015.
The Company is neither under examination by any taxing authority, nor has it been notified of any impending examination. The Company's tax years for its Federal and State jurisdictions which are currently open for examination are the years of 2012 - 2016.
China
Under the Law of People’s Republic of China on Enterprise Income Tax (“EIT Law”), which was effective from January 1, 2008, domestically-owned enterprises and foreign-invested enterprises are subject to a uniform tax rate of
25%. As of December 31, 2016, the PRC entities have net operating losses carry forward of $30
million that begin expiring in 2035. The potential benefit of the company’s net operating losses has not been recognized in these financial statements because it is more likely-than-not it will not utilize the net operating losses carried forward as it does not expect to generate sufficient taxable income in future or the amount involved is not significant.
| Year Ended December 31, | ||||||
| 2016 | 2015 | |||||
| Tailong Zhongrui International Corporation | $ | (34% | ) | $ | (34% | ) |
| Beijing De Qiuhong Investment Ltd. | 8.0% | 8.0% | ||||
| Xinxiang Tianjieshan Biotechnology Co., Ltd. | 2.6% | 2.6% | ||||
| Qingdao cooperation win - win Trading Company | $ | - | $ | - |